IL27 and HIV-1 infection: On the other hand, several in vitro studies have shown that IL-27 reduces HIV-1 infection in all types of HIV-1-target cells, such as peripheral blood mononuclear cells (PBMCs), CD4+ T cells, monocyte-derived macrophages, and dendritic cells (16, –, 20).